Kimmerling, Robert J. http://orcid.org/0000-0002-8920-336X
Stevens, Mark M.
Olcum, Selim
Minnah, Anthony
Vacha, Madeleine
LaBella, Rachel
Ferri, Matthew http://orcid.org/0000-0003-1265-2834
Wasserman, Steven C.
Fujii, Juanita
Shaheen, Zayna
Sundaresan, Srividya
Ribadeneyra, Drew
Jayabalan, David S.
Agte, Sarita
Aleman, Adolfo
Criscitiello, Joseph A.
Niesvizky, Ruben
Luskin, Marlise R. http://orcid.org/0000-0002-5781-4529
Parekh, Samir http://orcid.org/0000-0001-9694-8469
Rosenbaum, Cara A.
Tamrazi, Anobel
Reid, Clifford A. http://orcid.org/0000-0002-9438-9349
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R43 CA228872-01A1)
Article History
Received: 1 June 2022
Accepted: 16 November 2022
First Online: 26 November 2022
Change Date: 6 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-022-04376-8
Competing interests
: R.J.K., M.M.S., S.O., and C.A.R. are founders of Travera, which is commercializing SMR technology for clinical use. R.J.K., M.M.S., S.O., A.M., M.V., R.L., and C.A.R. are employees of Travera. M.F., S.W., and A.T. receive consulting fees from Travera. The remaining authors declare no competing interests.